Next generation theranostic pair offers new strategy to detect and treat metastatic kidney cancer
Researchers have developed a new radiotheranostic pair, 68 Ga/177 Lu-NYM096, to detect and treat metastatic clear cell renal cell carcinoma. This small-molecule approach targets the CAIX enzyme to improve precision and reduce toxicity in patients.
Why it matters
Represents a significant advancement in oncology, potentially offering safer and more effective treatment options for patients with advanced kidney cancer.
by Society of Nuclear Medicine and Molecular Imaging
edited by Gaby Clark , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in